|
Volumn 314, Issue 12, 2015, Pages 1291-1293
|
Long-term follow-up of a randomized trial of radiation with or without androgen deprivation therapy for localized prostate cancer
|
Author keywords
[No Author keywords available]
|
Indexed keywords
PROSTATE SPECIFIC ANTIGEN;
ANTIANDROGEN;
AGE;
ANDROGEN DEPRIVATION THERAPY;
CANCER MORTALITY;
CANCER PROGNOSIS;
CANCER RADIOTHERAPY;
CASTRATION RESISTANT PROSTATE CANCER;
CAUSE OF DEATH;
COMORBIDITY;
CONTROLLED STUDY;
FOLLOW UP;
HEART INFARCTION;
HUMAN;
LETTER;
MAJOR CLINICAL STUDY;
MALE;
OVERALL SURVIVAL;
PRIORITY JOURNAL;
PROSTATE CANCER;
UNITED STATES;
CLINICAL TRIAL;
HEART DISEASE;
MORTALITY;
MULTICENTER STUDY;
MULTIMODALITY CANCER THERAPY;
PROCEDURES;
PROPORTIONAL HAZARDS MODEL;
PROSTATIC NEOPLASMS;
RANDOMIZED CONTROLLED TRIAL;
ANDROGEN ANTAGONISTS;
CAUSE OF DEATH;
COMBINED MODALITY THERAPY;
COMORBIDITY;
FOLLOW-UP STUDIES;
HEART DISEASES;
HUMANS;
MALE;
PROPORTIONAL HAZARDS MODELS;
PROSTATIC NEOPLASMS;
|
EID: 84942279188
PISSN: 00987484
EISSN: 15383598
Source Type: Journal
DOI: 10.1001/jama.2015.8577 Document Type: Letter |
Times cited : (118)
|
References (6)
|